This compound is a modified nucleoside used as a building block in oligonucleotide synthesis. It features a purine base with an isobutyramide protecting group and a dimethoxytrityl (DMT) protecting group on the sugar moiety, which is typical for solid-phase DNA/RNA synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 114745-26-5
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine
pharmaceutical intermediate
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(tert-butyl)dimethylsilyl]-N-(2-methyl-1-oxopropyl)guanosine
pharmaceutical intermediate
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
pharmaceutical intermediate
5'-O-Dimethoxytrityl-N-isobutyryl-deoxyguanosine
pharmaceutical intermediate
Methyl 4'-methylbiphenyl-2-carboxylate
pharmaceutical intermediate
Methyl 4'-bromomethyl biphenyl-2-carboxylate
pharmaceutical intermediate
Tert-butyl 4'-(bromomethyl)biphenyl-2-carboxylate
pharmaceutical intermediate
2-cyano-4'-methylbiphenyl
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
ISQLJOGRNUQHJX-WIFIACMTSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC